Individuals with schizophrenia are burdened with impairments in functional outcome, despite existing interventions. The lack of understanding of the neurobiological correlates supporting adaptive function in the disorder is a significant barrier to developing more effective treatments. This research conducted a systematic and meta-analytic review of all peer-reviewed studies examining brain-functional outcome relationships in schizophrenia. A total of 53 (37 structural and 16 functional) brain imaging studies examining the neural correlates of functional outcome across 1631 individuals with schizophrenia were identified from literature searches in relevant databases occurring between January, 1968 and December, 2016. Study characteristics and results representing brain-functional outcome relationships were systematically extracted, reviewed, and meta-analyzed. Results indicated that better functional outcome was associated with greater fronto-limbic and whole brain volumes, smaller ventricles, and greater activation, especially during social cognitive processing. Thematic observations revealed that the dorsolateral prefrontal cortex, anterior cingulate, posterior cingulate, parahippocampal gyrus, superior temporal sulcus, and cerebellum may have role in functioning. The neural basis of functional outcome and disability is infrequently studied in schizophrenia. While existing evidence is limited and heterogeneous, these findings suggest that the structural and functional integrity of fronto-limbic brain regions is consistently related to functional outcome in individuals with schizophrenia. Further research is needed to understand the mechanisms and directionality of these relationships, and the potential for identifying neural targets to support functional improvement.
Introduction
Schizophrenia is a debilitating psychiatric condition characterized by pronounced disability across many domains of functional outcome, [1] [2] [3] yet very little is known about the neurobiological correlates that may contribute to poor functional outcomes in the disorder. Presently, a literature search in relevant databases, such as Medline, yields over 30 000 functional magnetic resonance imaging (fMRI) and MRI reports that have provided evidence that schizophrenia has a strong neurobiological etiology. 4 Despite this abundance of studies, very few have had a primary goal to understand the association between brain abnormalities and community and daily living in this population. Understanding the association between neurobiology and adaptive function may shed light on the neural targets and associated cognitive and behavioral mechanisms that can support functional improvement. Therefore, a systematic and meta-analytic review of the current literature with the goal of identifying brain correlates of functional outcome in schizophrenia could help identify novel directions for treatment of this domain.
Individuals diagnosed with schizophrenia have poor outcomes in social functioning, 5, 6 occupational/vocational functioning, 7 independent/community living, 8 and quality of life. 9 Impairments in these domains of functional outcome are observed in the premorbid stage, at first onset, and into the chronic stages of the illness. 10, 11 Epidemiological studies have shown that compared to other forms of psychosis, functional disability is the most substantial in people diagnosed with schizophrenia. 12 In a longitudinal study of long-term outcomes in schizophrenia at the National Institute of Mental Health (NIMH) it was observed at a mean follow-up period of 6 years that only 2 out of 58 patients had good global functioning, 66% were unemployed, and 50% had no social contacts. 13 More recently, Harvey and colleagues 14 examined the prevalence of impaired functioning by reviewing recipients of disability benefits with schizophrenia-related disorders. They observed that functional disability was stable and common across typical working ages, such that remission from symptomatic outcomes was more frequently observed than remission from functional disability. 14 Despite ample evidence that poor functional outcomes are an obvious global burden in schizophrenia, both pharmacological and psychosocial treatments have had only incremental success at rehabilitating community and daily living in this population. The NIMH Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study observed that antipsychotic medications provided only minor improvements in community functioning in people with schizophrenia, and efficacy did not differ between newer and older pharmacological treatments. 15 Psychosocial treatments have been moderately successful at improving functional outcome in schizophrenia, 16 with notable examples in cognitive remediation, 17 cognitive behavior therapy, 18 supported employment, 19 and other areas, but there remains considerable room for improvement. Schizophrenia is clearly associated with brain dysfunction, 20 which has been linked to impairments in clinical and cognitive outcomes. [21] [22] [23] [24] [25] Unfortunately, the neural substrates supporting functional outcome in schizophrenia are largely unknown, and such information is essential for developing empirically-driven disorder-relevant treatment targets to improve functioning in this population.
The purpose of this research was to conduct a comprehensive systematic and meta-analytic review of the existing and diverse literature examining brain-functional outcome relationships in schizophrenia. Specifically, we sought to elucidate consistent regional and directional (eg, increased or decreased brain volumes associated with functional outcome) themes of relationships between brain structure, brain function, and functional outcome in schizophrenia, with the goal of identifying neural treatment targets that could support improved adaptive function in this population.
Methods

Literature Search
An extensive literature search was conducted to locate peer-reviewed published studies examining the structural and functional neurobiological correlates of functional outcome in schizophrenia following the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) guidelines. 26 This method was implemented by performing keyword database searches in PsycINFO and Medline from January, 1968 until December, 2016. The search strings included (1) "schizophrenia" or "schizoaffective"; (2) "social functioning" or "social dysfunction" or "functional outcome" or "community functioning" or "quality of life" or "life satisfaction" or "well-being" or "social skills" or "social behavior" or "occupational functioning" or "vocational functioning" or "independent living" or "employment"; and (3) "brain" or "MRI" or "imaging" or "activation" or "gray matter". In addition, references from relevant studies were examined for other neuroimaging reports of functional outcome in schizophrenia.
In total, this review yielded 484 articles. The abstracts from these studies were reviewed and included if they (1) used quantitative structural or functional neuroimaging methodologies that provided specific information about anatomical locations in the brain, (2) reported data on participants diagnosed with schizophrenia, schizoaffective, or schizophreniform disorder only, (3) used a previously validated assessment of functional outcome, and (4) reported quantifiable findings on the relationship between neurobiology and functional outcome. Exclusion criteria were: (1) the sample did not consist only of people diagnosed with schizophrenia, schizoaffective, or schizophreniform; (2) the use of a neuroimaging methodology with low spatial resolution limiting the precise anatomical loci of activation associated with functional outcome (eg, near-infrared spectroscopy [NIRS]); (3) a qualitative approach to examine brain abnormalities related to functional outcome (eg, Galderisi et al 27 ); and (4) not reporting quantitative findings.
The majority of the articles (381) were excluded, as while implications for functional outcome were often suggested, no relationships between measures of neurobiology and functioning were analyzed. After screening out the above 381 articles, 102 full-text studies remained and were reviewed further for eligibility. Of those 102 studies, 22 were excluded because they did not examine functional outcome; 12 were excluded because their sample included other psychotic or mental disorders; 12 used neuroimaging methodologies that could not determine the specific anatomical loci of alteration (eg, NIRS); and 4 were review articles.
Study Coding Procedures
After gathering and organizing the studies included in this review, we systematically extracted relevant study characteristics. The study characteristics gathered included the sample size (N), average age, percent of males, illness duration, clinical status, presence of antipsychotic medication, design of the study (cross-sectional or longitudinal), scan type, measurement of brain structure (eg, gray matter volume, fractional anisotropy) or function (eg, activation, regional cerebral blood flow), the domain of functional outcome assessed, and the functional outcome measure utilized. None of the longitudinal studies were treatment trials, and thus all were naturalistic follow-up examinations. For the structural imaging studies that presented both relative and absolute brain volumes, priority was given to utilizing results from relative volumes due to their adjustment for brain size. The structural study findings were organized by brain lobe as a way to identify regional themes underlying functioning in individuals with schizophrenia. The functional studies were quite varied with regard to the imaging methodology used (10 social-cognitive fMRI; 1 neurocognitive fMRI, 3 restingstate fMRI, and 2 SPECT), cognitive tasks, and findings. Therefore, the functional findings were organized by neuroimaging methodology.
Study Analysis
After coding study characteristics, we extracted the statistics representing the relationships between brain regions and functional outcome (eg, r, pr, β) and/or the differences between patients with good compared to poor functional outcome (eg, t, F). All extracted data were converted to a common r metric using the equations provided in Rosenthal. 28 When appropriate, the directional relationship between brain regions and functional outcome was inversed (multiplied by −1), such that higher values represented associations with better functional outcome. Meta-analyses were conducted in R (3.1.2) with the Meta-Analysis Package for R. 29 Random-effects metaanalytic models were used to calculate average effect sizes for the various structural lobar locations (whole brain, white matter tracts, ventricles, frontal, limbic, temporal, parietal, occipital, and cerebellum) and functional imaging methodologies (social cognitive fMRI, neurocognitive fMRI, resting-state fMRI, and SPECT). Meta-regression models were also conducted to examine the possible moderating effects of illness duration (first episode vs multiple episode), clinical status (inpatient vs outpatient vs both), and treatment exposure (antipsychotic medication naïve vs presence of antipsychotic medication), wherever such data were available. These characteristics for each study are presented in table 1. Moderator analyses were only conducted on imaging domains with 5 or more studies (accounting for overlapping samples across study reports). Further, sample size was quite diverse (N range: 12-130; table 1) and there were several studies that utilized the same sample or subsample of participants across multiple reports. [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] Thus, all meta-analytic models accounted for the range of sample sizes by weighting effect sizes by their inverse variances (reflective of sample size) 46 and sample dependency by using a sample identifier as the random nesting factor to account for correlated findings across overlapping samples.
Results
Included Studies
A total of 53 neuroimaging studies (37 structural and 16 functional) met inclusion criteria and were used to examine relationships between brain structure, brain function, and functional outcome in schizophrenia (table 1) . There was a total of 1631 individuals with schizophrenia included; 1187 from the structural imaging studies and 444 from the functional imaging studies. A total of 268 findings were extracted across these 53 studies, of which 186 (69%) reported on a significant or trend-level (eg, P ≤ .10) relationship between brain structure or function and functional outcome, and 82 (31%) were nonsignificant (eg, P > .10). Across all samples, the percentage of males ranged from 20%-100%, with the majority (38 [72%] ) including more males than females with schizophrenia. The average study age ranged from 19.6 to 43.0, with a minority of the studies (9 [17%]) focused specifically on participants experiencing a first episode of psychosis. The domains of functional outcome examined were classified based on the methodological details contained in each study and included composite functioning (eg, more than one functional outcome domain included in the measure), global functioning (eg, GAF 85 ), social functioning, resource needs, quality of life, socioeconomic status, independent living, employment, and role functioning. Over half (56%) of the studies used a composite measure of functional outcome.
Results of Studies of Brain Structure and Functional Outcome in Schizophrenia
Thirty-seven studies were obtained that reported a total of 199 findings on the relationship between brain structure and functional outcome in schizophrenia (table 2). The findings are summarized according to lobar location. Globally, 21 (21:199) findings indicated that greater whole brain volumes (eg, total brain, gray matter) were associated with better functioning across diverse outcome domains, ranging from global functioning to resource needs to independent living. The average effect size for whole brain findings was significant, but small with significant heterogeneity between the studies ( Partial correlation (pr). *P < .05; **P < .01; ***P < .001; ****P < .10. Note: SPECT, single photon emission computed tomography. *P < .05; **P < .01; ***P < .001.
average effect was medium in size and significant heterogeneity was present among the limbic studies (table 3) . Illness duration was observed to significantly moderate the relationship between limbic regions and functional outcome (Q B (1) = 4.47, P = .034). A large effect size was demonstrated for the first episode patients (r = .59, P < .0001) and a medium effect size for the multiple episode patients (r = .30, P < .0001). No other significant moderating effects were observed. The limbic brain regions most commonly associated with functional outcome were the parahippocampal gyrus (17%), posterior cingulate (15%), anterior cingulate (13%), and the insula (13% ;  table 2 ). The average effect for the relationship between temporal brain regions (16:199) and functional outcome was not significant. A small, significant average effect was shown between greater parietal regional brain volume (15:199) and better functional outcome, with significant heterogeneity between studies (table 3) . Comparatively, fewer findings were observed in the occipital lobe (10:199) and cerebellum (10:199) . Greater volume in the occipital lobe (medium average effect size) and cerebellum (small average effect size) was significantly related to better functioning, with significant heterogeneity among studies examining the occipital lobe (table 3) . Moderator analyses were not conducted for the white matter tracts, temporal, parietal, and occipital findings due to an insufficient number of studies.
There were several studies (19, 36%) that used a categorical definition of good and poor functional outcome in schizophrenia, with most using outcome criteria from Keefe et al 84 (table 1) . Using a categorical vs continuous operationalization of functional outcome could have impacted effect size estimates of the association with neurobiological parameters in such studies. However, as can be seen in supplementary table 1, a sensitivity analysis demonstrated that using a continuous vs categorical definition did not bias the association between the major themes of smaller lateral ventricles and greater frontolimbic gray matter and better functional outcome. The effect sizes remained significant and moderate in size.
Overall, the structural results suggest a potentially central relationship between better functional outcome and greater whole brain and fronto-limbic gray matter and smaller ventricles in individuals with schizophrenia.
Results of Studies of Brain Function and Functional Outcome in Schizophrenia
Sixteen studies reported a total of 69 findings on the relationship between brain function and functional outcome in schizophrenia. These findings were organized by neuroimaging methodology and presented in table 4. There were a total of 42 (42:69) findings extracted from the social cognitive fMRI studies that had a significant, but small relationship with functional outcome (table 3) . The social cognitive fMRI findings were significantly heterogeneous, but no significant moderators were observed. The most frequent observations were that greater activation in the medial prefrontal cortex (MPFC; 12%), anterior cingulate (12%), and amygdala (12%) during social cognitive processing was associated with better composite, social, and role functioning. Only 1 (1:69) study examined the association between neurocognitive-related brain functioning and functional outcome. Greater resting-state connectivity (13:69), mostly in frontal areas, was significantly related to better global and social functioning with a medium effect size and homogeneity among the findings (table 3) . Regional cerebral blood flow, mostly in the superior temporal sulcus, measured by SPECT was not significantly related to functional outcome in schizophrenia. There were an insufficient number of SPECT studies to examine moderator effects.
Overall, the studies of brain function suggest that individuals with schizophrenia who elicit greater brain activation while performing social cognitive tasks or brain connectivity at rest have better functional outcome (r = .25, P = .004; Q W (66) = 359.62, P < .0001). No significant moderators were observed for the overall effect of the functional imaging studies.
Neurobiological Correlates of Functional Outcomes in Schizophrenia
In figure 1 , we combined the structural and functional imaging findings and their domains of functional outcome in order to visually inspect brain-functional outcome themes in schizophrenia across all the 268 findings. Brain regions and the number of findings contributing to that brain region were subjected to a scree plot, which indicated that brain-functional outcome relationships with 8 or more findings were the most frequent. An overlay of these regions across a T1 template brain is presented in figure 2 . The brain regions most commonly associated with functional outcome across all studies and modalities were the lateral ventricles (18:268), anterior cingulate (12:268), DLPFC (12:268), superior temporal sulcus (11:268), parahippocampal gyrus (9:268), posterior cingulate (8:268), and cerebellum (8:268; figure 2 ). The domains of functional outcome related to these regions included composite, global functioning, social functioning, resource needs, independent living, role functioning, and quality of life (figure 1). The measures of composite functioning dominated these relationships making associations between brain regions and specific domains of functional outcome inconclusive. Prominent directional themes suggested that having (1) smaller lateral ventricles; (2) greater parahippocampal gyrus, posterior cingulate, and cerebellum gray matter volume; and (3) greater activation and/or gray matter volume in the anterior cingulate, DLPFC and superior temporal sulcus were related to better functional outcome in the illness. 
Discussion
Individuals diagnosed with schizophrenia have pronounced impairments across many domains of functional disability 1,2,13,14 that have only been modestly responsive to pharmacological 15 and psychosocial interventions. 16, 88 A critical barrier to providing a more complete improvement in functional outcome is the limited understanding of the link between neurobiology and functional outcome in schizophrenia. Therefore, this research sought to systematically examine previous neuroimaging studies in order to elucidate common themes of brain-functional outcome relationships in the illness. Our goal was to establish an initial neurobiological basis of functional outcome that could function as a treatment biomarker and serve to direct future investigations. A total of 53 neuroimaging studies were identified that examined functional outcome in schizophrenia: 37 used structural and 16 used functional neuroimaging. The studies yielded a total of 1631 individuals with schizophrenia and 268 findings of brain-functional outcome relationships, of which 199 were structural and 69 were functional. The studies of brain structure suggested that Note: DLPFC, dorsolateral prefrontal cortex; MPFC, medial prefrontal cortex; NP-SCZ, nonparanoid schizophrenia; P-SCZ, paranoid schizophrenia; rCBF, regional cerebral blood flow; SPECT, single photon emission computed tomography. a Spearman's rank correlation (r s ). *P < .05; **P < .01; ***P < .001; ****P < .10. individuals with schizophrenia who displayed better functional outcome had smaller ventricles and greater gray matter volumes across the cortex and in fronto-limbic regions. The relationship between functional outcome and limbic volume was significantly moderated by illness duration, suggesting that interventions, such as cognitive remediation, applied early in the illness may be important for restoring or enhancing functional abilities. 89 Results from the functional studies were quite heterogeneous, but did indicate that individuals with schizophrenia who had better functional outcome had greater activation during social cognitive processing and/or greater connectivity while at rest. No significant moderators emerged in the functional imaging findings. Thematic observations across all the findings revealed that smaller lateral ventricles, greater parahippocampal gyrus, posterior cingulate, and cerebellum gray matter volume; and greater activation and/or gray matter volume in the anterior cingulate, DLPFC and superior temporal sulcus were most consistently associated with better functioning (figure 2). The commonality of using a composite measure of functional outcome among the studies made specific brainfunctional outcome domain (eg, employment or social functioning) relationships inconclusive.
The consistency of ventricular, fronto-limbic, and temporal results identified in this review preliminarily suggests neurocircuitry is associated with functional outcome in schizophrenia. Larger ventricles have generally been a key feature of poor functional outcome in the illness 41, 52, 61 and are reflective of progressive gray matter atrophy. 90 For example, Gaser and colleagues 91 showed that reductions in gray matter in the insula, thalamus, and putamen were related to larger ventricular volumes in patients with schizophrenia. Gray matter loss has been consistently reported in the disorder for many of the regions identified in this review. 92 Furthermore, impairments in social and nonsocial cognition are associated with reduced gray matter across fronto-limbic and temporal regions, including the medial/dorsolateral prefrontal, cingulate, superior/middle temporal, and hippocampal cortices. [93] [94] [95] [96] There is substantial overlap among these brain regions associated with cognitive impairments and the regions observed to be associated with functional outcome in this review. This is likely reflective of an important neurobiological link that could be targeted through intervention, specifically cognitive remediation, to promote functional recovery from schizophrenia. Indeed, a well-known and robust relationship exists between cognition and functional outcome in the illness. [97] [98] [99] Eack and colleagues have demonstrated improved cognition mediated the beneficial effects of cognitive remediation on functional outcome, 100 in addition to protecting against gray matter loss 101 and increasing resting-state network connectivity 102 that was associated with improved cognition. Examining treatment-related brain alterations and their mediating/ moderating role in functional treatment goals (ie, independent living, maintaining employment) is an important direction for future research and for discerning the specificity of these findings. The findings from this review suggest that the ability to maintain interpersonal relationships, live independently in the community, and work, eg, all may be partially related to having sufficient fronto-limbic brain resources. The onset of schizophrenia-spectrum disorders typically occurs during late adolescence or early adulthood and triggers substantial alterations to neuromaturation (eg, reduced gray matter 103 ), which could lead to major disruptions in meeting early adult developmental milestones. The insult to functional outcome made by reduced gray matter in fronto-limbic regions may be reflective of excessive synaptic pruning [104] [105] [106] that results in significant tissue loss 107 and broad cognitive dysfunction that extends to cognitive abilities that directly support adaptive function (eg, shifting from one task to the next, maintaining focus to understand information). Without treatment, 101, 108 impairments in fronto-limbic brain integrity may persist and have a distributed impact on many domains of community and daily living. Specific conclusions regarding the role of the fronto-limbic regions associated with functional outcome are limited with this being the first comprehensive review of a diverse and relatively small literature. These findings do imply, however, that frontolimbic, cortical, and ventricle parameters are potentially consistent correlates of changes to functional outcome. Preservation and restoration of fronto-limbic structure and function may be profitable for rehabilitating functional disability in schizophrenia. Greater baseline limbic and temporal gray matter volumes have been shown to be predictive of better outcomes following treatment in patients schizophrenia 109, 110 ("brain reserve" model 111 ). Despite the evidence for a neurobiological basis of functional outcome in schizophrenia, several limitations of this research should be considered. First, there was a large discrepancy between the number of findings from the structural (k = 199) and functional (k = 69) imaging studies. This gave more weight to fronto-limbic brain-structural outcome relationships and allowed for a more stable structural pattern to emerge. The functional imaging studies also varied in scanner tasks, imaging modalities (eg, activation, connectivity), and measured a different neural process (blood flow) than structural imaging studies (primarily volume). These differences likely accounted for variations in brain-functional outcome findings between the structural and functional imaging methodologies. Although there were a limited number of functional neuroimaging findings, file drawer analyses indicated that a publication bias was not likely to be present for either the structural or functional imaging findings. A total of 42 135 unpublished null structural imaging findings and 1989 unpublished null functional imaging findings would be required to reduce meta-analytic results to non-significant levels.
Second, very few studies in this review had a primary aim to examine brain-functional outcome relationships. Most studies examined this relationship post-hoc after restricting brain regions to differences between groups (eg, controls or comparison groups) or hypothesized brain regions of interest. Such restrictions may be overlooking other central brain regions outside the frontallimbic theme observed. Third, the studies revealed that a large variety of measures of functional outcome were used, with most utilizing a composite assessment that limited conclusions that could be made about specific neurobiological associations with different domains of functioning (eg, social functioning, employment, independent living). Finally, given that few studies reviewed were longitudinal (18, 34%), the time-ordered direction of brain-functional outcome associations remains unknown. Based on the pathophysiology of schizophrenia, 105 it is perhaps predicted that neurobiology impacts community functioning. However, such an assumption would ignore existing evidence indicating that functional disability can contribute to neural dysfunction, especially in cases where functional impairment leads to deprivation. 112 In the context of schizophrenia, it is possible that early sensitivity to stress can lead to social isolation, which then interrupts healthy neurobiological development. 86 An alternative approach to examining brainfunctional outcome relationships in schizophrenia would be to examine premorbid functional changes, such as social isolation, that can negatively impact neurobiology.
Overall, the findings of this research indicate that there is a consistent relationship between brain structure and function, and functional outcome in people living with schizophrenia. The aforementioned limitations largely preclude further specification of these relationships beyond regional themes, but give clear direction for future research. First, a priori studies are greatly needed that are not limited to regions of interest and analyses based on post hoc decisions. Second, the collection of longitudinal data is essential, given the likelihood of bidirectional relationships between the brain and functional outcome. Longitudinal studies of first episode patients will be especially vital, given the need to provide prognostic information to patients and families, as well as allocating needed resources to those most likely to experience adverse outcomes. Third, the standardization of functional outcome measures would greatly improve the interpretability of this literature, and enable clearer conclusions regarding specific outcome domains. We are excited by work progressing in this area and encourage its use. 87, 113 Fourth, greater focus on functional neuroimaging modalities are needed, given the small number of functional imaging studies and heterogeneous results observed in this review. It will be important to consider the possibility of performance-based measures of functional capacity that could be adapted for use in the scanner, as well as neurocognitive tasks that may mediate the relationship between brain function and outcome. Finally, given the likelihood of several downstream mechanisms in the relationship between brain and functional outcome (eg, "brain reserve," neurocognitive function, social cognition), it will be important for future studies to conduct mediator analyses and begin to construct models that describe the direct and indirect effects of neural variables on functioning.
In summary, this comprehensive systematic and metaanalytic review was conducted to investigate neurobiological themes of functional outcome in schizophrenia. Overall, the meta-analytic results demonstrated that individuals with schizophrenia who had greater whole brain and fronto-limbic volumes, smaller ventricles, and greater activation during social cognitive processing had better functional outcome. Thematic observations revealed that better functional outcome was associated with smaller lateral ventricles and larger gray matter volumes in the parahippocampal gyrus, posterior cingulate, and cerebellum. Additionally, greater volume and/or activation in the DLPFC, anterior cingulate, and superior temporal sulcus were associated with better functional outcome. The results of this review provide preliminary evidence that fronto-limbic neurocircuitry is involved in functional outcome in schizophrenia, despite this literature base being limited and heterogeneous. Such findings support continuing to research and establish the neural correlates of functional outcome in schizophrenia, which is advantageous for intervention development and optimizing the capacity for full functional recovery from this illness.
Supplementary Material
Supplementary material is available at Schizophrenia Bulletin online.
Funding
National Institutes of Health (MH 95783 to S.M.E.).
